Why Did Scinai Plunge 11.08% Despite Italian Acquisition Clearance?

On June 6, 2025, Scinai's stock price plummeted by 11.08% during pre-market trading, marking a significant downturn for the biotech company.

Scinai Immunotherapeutics recently received clearance from the Italian government under the Golden Power Regulation for a potential acquisition of Pincell S.r.l. This regulatory approval is a crucial step in Scinai's strategic expansion, as it aims to enhance its portfolio and market presence in the biotech sector.

The clearance from the Italian government is a positive development for Scinai, as it paves the way for the company to proceed with its acquisition plans. This move is expected to strengthen Scinai's position in the biotech industry, potentially leading to future growth and innovation.